Metabolic Heterogeneity in Human Lung Tumors.
Hensley, Christopher T; Faubert, Brandon; Yuan, Qing; Lev-Cohain, Naama; Jin, Eunsook; Kim, Jiyeon; Jiang, Lei; Ko, Bookyung; Skelton, Rachael; Loudat, Laurin; Wodzak, Michelle; Klimko, Claire; McMillan, Elizabeth; Butt, Yasmeen; Ni, Min; Oliver, Dwight; Torrealba, Jose; Malloy, Craig R; Kernstine, Kemp; Lenkinski, Robert E; DeBerardinis, Ralph J.
; 164(4): 681-94, 2016 Feb 11.
Artigo em Inglês | MEDLINE | ID: mdl-26853473
Lung Cancer: A Wily Genetic Opponent.
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
The biology and management of non-small cell lung cancer.
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.
Postoperative radiotherapy for non-small cell lung cancer.
Local consolidative therapy may be beneficial in patients with oligometastatic non-small cell lung cancer.
Metabolic vulnerability in tumours illuminated.
Catastrophic nuclear envelope collapse in cancer cell micronuclei.